IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $98,408,520 | +10.6% | 2,169,500 | 0.0% | 2.09% | +29.6% |
Q2 2023 | $89,014,585 | +17.2% | 2,169,500 | +2.1% | 1.61% | +8.2% |
Q1 2023 | $75,929,630 | +0.8% | 2,124,500 | +6.6% | 1.49% | +3.5% |
Q4 2022 | $75,298,272 | +121.4% | 1,993,600 | +159.3% | 1.44% | +128.2% |
Q3 2022 | $34,008,000 | +102.6% | 768,900 | +69.6% | 0.63% | +107.6% |
Q2 2022 | $16,785,000 | +159.9% | 453,400 | +324.1% | 0.30% | +230.4% |
Q4 2019 | $6,458,000 | – | 106,900 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,913,172 | $330,657,000 | 12.25% |
TANAKA CAPITAL MANAGEMENT INC | 84,953 | $4,063,000 | 9.51% |
Sicart Associates LLC | 280,315 | $13,407,000 | 9.26% |
DOWLING & YAHNKE LLC | 675,843 | $32,326,000 | 3.62% |
Opus Point Partners Management, LLC | 77,550 | $3,709,000 | 2.96% |
Motley Fool Asset Management LLC | 259,000 | $12,388,000 | 2.75% |
Motley Fool Wealth Management, LLC | 333,604 | $15,956,000 | 1.70% |
ALTRINSIC GLOBAL ADVISORS LLC | 921,174 | $44,060,000 | 1.63% |
PINNACLE ASSOCIATES LTD | 1,572,045 | $75,191,000 | 1.52% |
Sonora Investment Management, LLC | 121,703 | $5,821,054,000 | 1.20% |